ProVeg launches GLP-1 nutrition guide to help health professionals support patients beyond medication

As the use of GLP-1 therapies continues to grow, ProVeg International has launched a new evidence-informed nutrition guide aimed at helping healthcare professionals support patients in maintaining dietary quality and nutritional adequacy while undergoing treatment.

• ProVeg International has published a nutrition roadmap for healthcare professionals supporting patients on GLP-1 therapies
• The guide focuses on maintaining protein intake, fibre consumption and overall dietary quality as food intake decreases
• The resource emphasizes that nutrition and lifestyle remain essential alongside medication for long-term health outcomes

The new brochure, Better Results, Starting Now: Your Nutrition Roadmap for GLP-1 Therapy, has been developed to translate emerging nutrition evidence into practical guidance for clinicians working with people using GLP-1 medications for obesity treatment and weight management.

According to ProVeg, while GLP-1 therapies help regulate appetite and support weight loss, they do not reduce the body's nutritional requirements. Instead, lower food intake makes the nutritional quality of every meal increasingly important.

"GLP-1 therapy changes appetite, but not nutritional needs," said Anna-Lena Klapp, Head of Research at ProVeg International and one of the lead authors of the brochure.

"When people eat less, every meal matters more. Health professionals increasingly need practical, evidence-informed resources that help patients maintain nutritional quality while building sustainable eating habits alongside treatment."

The organization says the publication addresses what it sees as a gap between clinical treatment and practical dietary guidance for patients.

Developed by a multidisciplinary team with expertise spanning nutrition, public health and food technology, the brochure examines strategies for supporting nutritional adequacy during GLP-1 therapy through dietary quality, nutrient density, symptom management and long-term behavior change.

A central theme of the guide is the role that plant-forward eating patterns can play during treatment. ProVeg notes that patients using GLP-1 therapies often prefer lighter, smaller meals, making nutrient density an increasingly important consideration.

The organization says high-fibre, nutrient-dense plant foods can support gut health, help stabilize blood sugar, increase satiety and improve overall dietary quality. As overall food consumption declines, ensuring sufficient protein and fibre intake also becomes more important to help preserve muscle mass and support positive health outcomes.

The brochure outlines several practical considerations for healthcare professionals, including supporting adequate protein intake during weight loss, prioritizing nutrient-dense foods when portion sizes become smaller, managing gastrointestinal side effects through dietary strategies, maintaining hydration and fibre intake to support digestive comfort, and encouraging physical activity alongside long-term healthy eating habits.

Rather than positioning nutrition as an alternative to medication, the publication emphasizes that dietary support should complement pharmacological treatment.

"Long-term outcomes depend on more than appetite suppression alone," Klapp said. "Nutrition and lifestyle remain essential components of patient support. We aim to contribute practical guidance that helps translate emerging evidence into everyday conversations between healthcare professionals and patients."

ProVeg also stresses that the brochure is designed to support, rather than replace, professional medical and nutritional advice, with recommendations intended to be tailored to individual patient needs.

The guide forms part of the organization's wider work examining the relationship between nutrition, public health and emerging food system trends, with a particular focus on making plant-forward dietary approaches practical, accessible and evidence-informed for both healthcare professionals and patients.